The Effect of Robotics-assisted Tilt Table and Functional Electrical Stimulation in Stroke Patients

Sponsor
Yonsei University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04654793
Collaborator
(none)
48
1
2
71.5
0.7

Study Details

Study Description

Brief Summary

Among subacute stroke patients (within 4 weeks after the onset), patients who are unable to walk are divided into experimental groups and control groups, and conventional rehabilitation treatment including physical therapy and occupational therapy is performed for 4 weeks or more in all groups.

Robot assisted inclined bed treatment and FES were performed, and the control group performed conventional inclined bed treatment.

The purpose of this study is to investigate the effect of robot-assisted inclined bed treatment by tracking observation and comparative analysis of the lower limb function, gait ability, bone density and muscle mass of each group.

Patients appropriate for the selection criteria are divided into experimental group and control group in random permuted blocks to conduct the study. In the experimental group, FES was performed at the same time as the robot-assisted inclined bed treatment once a day for 30 minutes, 5 days a week for 4 weeks, and the control group performed conventional inclined bed treatment for 30 minutes once a day for 4 weeks, 5 days a week. Separately from this in all groups, functional electrical stimulation treatment is performed once a day in the area except the lower extremities. In addition, all patients receive palliative physical therapy for 4 weeks for 1 hour a day. All subjects undergo a physical examination and whole body composition assessment before and after 4 weeks of treatment, and f/u after 4 weeks of treatment.

Condition or Disease Intervention/Treatment Phase
  • Device: Robot assisted inclined bed treatment and FES
  • Device: conventional inclined bed treatment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Robotics-assisted Tilt Table and Functional Electrical Stimulation in Stroke Patients
Actual Study Start Date :
Mar 17, 2017
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Robot assisted inclined bed treatment and FES

Device: Robot assisted inclined bed treatment and FES
FES was performed at the same time as the robot-assisted inclined bed treatment once a day for 30 minutes, 5 days a week for 4 weeks.

Active Comparator: Control group

conventional inclined bed treatment

Device: conventional inclined bed treatment
conventional inclined bed treatment for 30 minutes once a day for 4 weeks, 5 days a week

Outcome Measures

Primary Outcome Measures

  1. Fugl-Meyer Assessment (lower) [before intervention]

    A tool used to evaluate motor dysfunction, movement of the agonist and collaborator muscles, and coordination in stroke patients. It is used to evaluate motor function of the affected side.

  2. Fugl-Meyer Assessment (lower) [4weeks after]

    A tool used to evaluate motor dysfunction, movement of the agonist and collaborator muscles, and coordination in stroke patients. It is used to evaluate motor function of the affected side.

  3. Fugl-Meyer Assessment (lower) [8weeks after]

    A tool used to evaluate motor dysfunction, movement of the agonist and collaborator muscles, and coordination in stroke patients. It is used to evaluate motor function of the affected side.

  4. Motricity Index [before intervention]

    A tool used to evaluate motor power.

  5. Motricity Index [4weeks after]

    A tool used to evaluate motor power.

  6. Motricity Index [8weeks after]

    A tool used to evaluate motor power.

  7. FAC (Functional ambulatory scale) [before intervention]

    A tool to evaluate the independence of walking by measuring the degree of assistance required when walking. It is rated as 0-5 points.

  8. FAC (Functional ambulatory scale) [4weeks after]

    A tool to evaluate the independence of walking by measuring the degree of assistance required when walking. It is rated as 0-5 points.

  9. FAC (Functional ambulatory scale) [8weeks after]

    A tool to evaluate the independence of walking by measuring the degree of assistance required when walking. It is rated as 0-5 points.

  10. Locomotion level of FIM (functional independence measure) [before intervention]

    Indicator to evaluate independence in performing daily life movements

  11. Locomotion level of FIM (functional independence measure) [4weeks after]

    Indicator to evaluate independence in performing daily life movements

  12. Locomotion level of FIM (functional independence measure) [8weeks after]

    Indicator to evaluate independence in performing daily life movements

  13. Berg balance scale [before intervention]

    A tool to evaluate balance

  14. Berg balance scale [4weeks after]

    A tool to evaluate balance

  15. Berg balance scale [8weeks after]

    A tool to evaluate balance

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients within 4 weeks of onset of first stroke

  2. Patients with an FAC score of 1 or less and at least one lower limb FMA of 15 or less

  3. Adult male or female over 50 years of age

  4. Those who have consented in writing to this clinical trial

  5. A person who understands the purpose of the clinical trial and can adapt well to the treatment process

Exclusion Criteria:
  1. Those with lower motor neuron lesions

  2. A person who has an artificial implant due to a fracture of the lower extremity and spine, or a metal implant that generates an electrical signal such as an artificial pacemaker.

  3. Those with a history of bone metabolism related diseases such as thyroid or parathyroid disease (excluding osteopenia and osteoporosis) or bone tumor

  4. A person who has a history of fracture at the site of bone mineral density (ex. L1-L5, femoral head)

  5. Those who have skin ulcers or skin diseases such as open wounds that make it difficult to apply robotic therapy

  6. Those with the construction of the lower extremities

  7. Those with deep vein thrombosis or arterial vascular disease of the lower extremities

  8. Pregnant women

  9. Not appropriate according to the judgment of other researchers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yonsei Severance Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Yonsei University

Investigators

  • Principal Investigator: Deog Young Kim, Severance Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT04654793
Other Study ID Numbers:
  • 4-2017-0092
First Posted:
Dec 4, 2020
Last Update Posted:
Dec 4, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 4, 2020